Home / Cardiovascular system / Methyldopa (Levorotatory) and Diuretics
ATC C02LB01 · Methyldopa and Diuretics in Combination · updated 2 Nov 2026
Methyldopa (Levorotatory) and Diuretics shortage
As of 2 Nov 2026, Methyldopa (Levorotatory) and Diuretics has a reported shortage in 1 of the 16 countries we track (Canada), covering 2 products from 1 company.
Is there a Methyldopa (Levorotatory) and Diuretics shortage?
Yes. As of 2 Nov 2026, Methyldopa (Levorotatory) and Diuretics is reported short in 1 of the 16 countries we track: Canada. No company has given a return date.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO METHAZIDE 15 (100 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO METHAZIDE 25 (100 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Methyldopa (Levorotatory) and Diuretics shortage?
Yes. As of 2 Nov 2026, Methyldopa (Levorotatory) and Diuretics is reported short in 1 of the 16 countries we track: Canada. No company has given a return date.
When will Methyldopa (Levorotatory) and Diuretics be back in stock?
No return date has been given; Canada: no date given. These are company estimates reported to each authority.
Why is Methyldopa (Levorotatory) and Diuretics in short supply?
The most common reason reported is: manufacturing problem. Reasons by product are listed in the table below.
Which companies have Methyldopa (Levorotatory) and Diuretics shortages?
Apotex.